Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
AHI reduction of 32% average with 15% weight loss CPAP discontinuation possible for 25 to 40% of users achieving 20%+ weight loss Oxygen saturation improvements averaging 4 to 6 percentage points Snoring reduction reported by 78% of users losing 30+ pounds Faster Sleep Onset Many users report falling asleep more quickly once they move past the initial weeks of treatment
R.BourdetD
doi: 10.1016/j.spen.2020.100835
For many adults with obesity or weight-related health problems, the potential benefits of GLP-1 treatment can outweigh the risks when the medication is prescribed and monitored by a licensed provider
US$ 27.40
US$ 21.07
US$ 26.23
